Clinical Research Directory
Browse clinical research sites, groups, and studies.
Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma
Sponsor: Oslo University Hospital
Summary
A study to determine the feasibility and safety of individualized cancer stem cell targeted therapy based on high-throughput functional profiling of FDA/EMA-approved drugs in patients with GBM that has recurred or progressed following standards-of-care (RT, TMZ).
Official title: Individualized Systems Medicine Strategy for Targeting Cancer Stem Cells in Patients With Recurrent Glioblastoma (ISM-GBM)
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2023-03-01
Completion Date
2026-02
Last Updated
2024-04-03
Healthy Volunteers
No
Conditions
Interventions
Personalized drug combination
A personalized drug combination will be prescribed to each patient based on the functional drug screen
Locations (1)
Oslo University Hospital
Oslo, Norway